Australia appears to be gain access to a groundbreaking treatment for obesity: Retatrutide. This new dual molecule – targeting on both GLP-1 and GIP receptors – has significant results in international research, suggesting meaningful reductions in body fat. While availability hasn't occurred with TGA, many individuals dealing with obesity could